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Abstract
Objective: To compare histopathological findings and the degree of apoptosis among rat lungs preserved with 
low-potassium dextran (LPD) solution, histidine-tryptophan-ketoglutarate (HTK) solution, or normal saline (NS) 
at two ischemia periods (6 h and 12 h) using an experimental rat model of ex vivo lung perfusion. Methods: Sixty 
Wistar rats were anesthetized, randomized, and submitted to antegrade perfusion via pulmonary artery with one 
of the preservation solutions. Following en bloc extraction, the heart-lung blocks were preserved for 6 h or 12 h 
at 4°C and then reperfused with homologous blood for 60 min in an ex vivo lung perfusion system. At the end of 
the reperfusion, fragments of the middle lobe were extracted and processed for histopathological examination. The 
parameters evaluated were congestion, alveolar edema, alveolar hemorrhage, inflammatory infiltrate, and interstitial 
infiltrate. The degree of apoptosis was assessed using the TdT-mediated dUTP nick end labeling method. Results: 
The histopathological examination showed that all of the lungs preserved with NS presented alveolar edema after 
12 h of ischemia. There were no statistically significant differences among the groups in terms of the degree of 
apoptosis. Conclusions: In this study, the histopathological and apoptosis findings were similar with the use of 
either LPD or HTK solutions, whereas the occurrence of edema was significantly more common with the use of NS.
Keywords: Organ preservation; Organ preservation solutions; Lung transplantation; Reperfusion injury; 
Apoptosis.
Resumo
Objetivo: Comparar os achados histopatológicos e de apoptose em pulmões de ratos preservados em soluções 
low-potassium dextran (LPD, baixo potássio dextrana), histidine-tryptophan-ketoglutarate (HTK, histidina-
triptofano-cetoglutarato) ou salina normal (SN) em 6 h e 12 h de isquemia pela utilização de um modelo 
experimental de perfusão pulmonar ex vivo. Métodos: Sessenta ratos Wistar foram anestesiados, randomizados e 
submetidos à perfusão anterógrada pela artéria pulmonar com uma das soluções preservadoras. Após a extração, 
os blocos cardiopulmonares foram preservados por 6 ou 12 h a 4°C, sendo então reperfundidos com sangue 
homólogo em um sistema de perfusão ex vivo durante 60 min. Ao final da reperfusão, fragmentos do lobo médio 
foram extraídos e processados para histopatologia, sendo avaliados os seguintes parâmetros: congestão, edema 
alveolar, hemorragia alveolar, hemorragia, infiltrado inflamatório e infiltrado intersticial. O grau de apoptose 
foi avaliado pelo método TdT-mediated dUTP nick end labeling. Resultados: A histopatologia demonstrou 
que todos os pulmões preservados com SN apresentaram edema alveolar após 12 h de isquemia. Não houve 
diferenças em relação ao grau de apoptose nos grupos estudados. Conclusões: No presente estudo, os achados 
histopatológicos e de apoptose foram semelhantes com o uso das soluções LPD e HTK, enquanto a presença de 
edema foi significativamente maior com o uso de SN. 
Descritores: Preservação de órgãos; Soluções para preservação de órgãos; Transplante de pulmão; 
Traumatismo por reperfusão; Apoptose.
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LPD solutions at two ischemia periods (6 and 
12 h) produced no significant differences among 
rat lungs in terms of physiological parameters, 
except for weight gain in the lungs undergoing 
12 h of ischemia.(11) 
The objective of the present study was to 
compare histopathological findings and the degree 
of apoptosis among rat lungs preserved with HTK 
solution, LPD solution, or normal saline (NS, 
0.9% saline solution), at two different periods 
of hypothermic ischemia using an experimental 
rat model of ex vivo lung perfusion. 
Methods 
In the present study, 60 male Wistar 
(weight, 250-300 g) were used. The animals 
were randomized into groups (10 rats/group) 
according to the different periods of ischemia and 
the perfusion solution used: LPD-6 group (LPD, 
6 h of ischemia); LPD-12 group (LPD, 12 h of 
ischemia); HTK-6 group (HTK, 6 h of ischemia); 
HTK-12 group (HTK, 12 h of ischemia); NS-6 
group (NS, 6 h of ischemia); and NS-12 group 
(NS, 12 h of ischemia). The composition of the 
preservation solutions are described in Table 1. 
The study was approved by the local animal 
research ethics committee. After having been 
anesthetized (pentobarbital, 50 mg/kg i.p.), the 
animals were tracheostomized and connected to 
a ventilator (IL2 - Isolated Perfused Rat or Guinea 
Pig Lung System; Harvard Apparatus, Holliston, 
MA, USA) set to a tidal volume of 10 mL/kg, a RR 
of 70 breaths/min, and a positive end-expiratory 
pressure (PEEP) of 3 cmH2O, on room air. The 
animals were anticoagulated (heparin, 1,500 IU, 
administered to the inferior vena cava). Further 
details on extraction and perfusion have been 
described elsewhere.(10,12) 
According to the randomization, perfusion 
was achieved with 20 mL of LPD solution 
(Perfadex®; Vitrolife, Kungsbacka, Sweden), 
HTK solution (Custodiol®; Franz Kohler Chemie 
GMBH, Bensheim, Germany), or NS, at 4°C, 
administered under a constant pressure of 20 
cmH2O by raising the flask. At the end of the 
perfusion, the heart-lung block was extracted 
and preserved for 6 h or 12 h, according to the 
predetermined randomization, being prepared and 
connected to the ex vivo lung perfusion system 
(IL2 - Isolated Perfused Rat or Guinea Pig Lung 
System; Harvard Apparatus, Holliston, MA, USA; 
Hugo Sachs Elektronik, Hugstetten, Germany). 
Introduction
Lung transplantation is the only definitive 
treatment modality for selected patients with 
end-stage lung disease. 
Over two decades, there has been a significant 
increase in the number of transplant centers, as 
well as in the number of transplant recipients or 
patients on waiting lists,(1) the mean annual number 
of lung transplants performed being higher than 
1,500.(2) However, pulmonary transplant-related 
mortality remains significant. Graft dysfunction 
is considered the most common cause of early 
mortality, and its etiopathogenesis lies in ischemia-
reperfusion injury.(3,4) 
Donor lung preservation plays a key role in 
early graft function after transplantation.(5) The 
presence and severity of ischemia-reperfusion 
injury are influenced by factors pertaining to 
the donor and to the preservation techniques.
(3) Ischemia-reperfusion injury is associated with 
cell death in various organ systems, and there is a 
correlation between the degree of apoptosis and 
ischemia-reperfusion injury.(6) During apoptosis, 
a well-regulated, energy-dependent cascade of 
events activates specific endonucleases, such as 
caspases, which are cysteine proteases specifically 
involved in the initiation and execution phases 
of apoptosis. 
Under the clinical lung transplant program 
in our hospital, low-potassium dextran (LPD) 
solution is used for lung preservation. However, the 
cost of the solution and the logistical difficulties 
in obtaining it led us to seek alternatives that 
are logistically more efficient and provide 
similar clinical benefits. Histidine-tryptophan-
ketoglutarate (HTK) solution is commonly used in 
heart transplantation at our institution. Therefore, 
the exclusive use of HTK solution under both 
transplant programs would be desirable in order 
to facilitate and reduce the cost-benefit ratio 
of preserving both organs. 
To date, there have been no experimental rat 
models of ex vivo lung perfusion with the use of 
HTK as the preservation solution, although there 
have been studies demonstrating the advantages 
of HTK use for heart, liver, kidney, and pancreas 
preservation.(7-9) 
Ex vivo lung perfusion models for the 
evaluation of new strategies for organ preservation 
have been shown to be effective and reliable in 
lung preservation studies.(10) We have recently 
demonstrated that the use of either HTK or 
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septal, and peripheral) interstitium, capillary 
bed, and extent of changes. Each change (event) 
was separately semi-quantified and received a 
score ranging from zero to three, as follows: 
no event (score 0); event occurring in less than 
33% of the affected compartments (score 1); 
event occurring in 33-66% of the affected 
compartments (score 2); and event occurring 
in more than 66% of the affected compartments 
(score 3).(13) Histological examination was performed 
by a single observer. The parameter “edema” 
was evaluated in two different compartments, 
namely the interstitial compartment and the 
bronchoalveolar compartment. Alveolar edema 
was scored with the semi-quantitative scoring 
system described above. 
Apoptosis was assessed using the TdT-mediated 
dUTP nick end labeling (TUNEL) method. The 
fragments of the middle lobe were processed 
in accordance with the instructions provided 
in the In Situ Cell Death Detection kit (Roche 
Diagnostics GmbH, Mannheim, Germany) and 
the methods described by Gavrieli et al.(14) and 
Rösl.(15) After deparaffinization in xylene, slides 
were pretreated with proteinase K (20 mg/mL) 
for 30 min in a humidified chamber at room 
temperature, washed in PBS, and treated with a 
solution of 3% oxygen peroxide in methanol for 
30 min at room temperature. Subsequently, the 
fragments were washed in PBS twice, and, after 
the area around the sample was dried, 50 μL of 
the TUNEL reaction mixture—5 μL of the enzyme 
solution (violet tube) and 45 μL of the labeling 
solution (blue tube)—were added to each lung 
The block was reperfused with homologous 
blood obtained from 3 similarly anesthetized 
animals, and the volume was increased by adding 
enough NS to achieve a hematocrit of 15-20%. 
Reperfusion was performed via cannulation of 
the pulmonary artery/left atrium and tracheal 
ventilation for 60 min. The circuit was filled with 
blood, which was heated and recirculated through 
the system for 10 min with a gas mixture (90% 
nitrogen and 10% carbon dioxide at a flow of 
200 mL/min) administered through a membrane 
oxygenator (D150 MediSulfone® Hemofilter; 
MEDICA s.r.l. Medolla, Italy). The heart-lung block 
was perfused (5-7 mL/min) and ventilated (tidal 
volume = 10 mL/kg, RR = 70 breath/min, and 
PEEP = 3 cmH2O). After 5-10 min, we started data 
collection, which was performed every 10 min 
for 60 min. We collected data on hemodynamics 
and respiratory mechanics, as well as blood gas 
analysis (ABL 800; Radiometer, Copenhagen, 
Denmark) results. At the end of the reperfusion, 
fragments of the middle lobe were extracted, 
fixed in 4% formaldehyde buffered solution, 
and embedded in paraffin blocks. Subsequently, 
5-μm sections were cut and stained with H&E. 
We conducted a qualitative and semi-quantitative 
analysis by assessing the following: congestion; 
alveolar edema; alveolar hemorrhage; interstitial 
hemorrhage; inflammatory infiltrate; and interstitial 
infiltrate. For the semi-quantitative assessment of 
changes such as alveolar hemorrhage, interstitial 
hemorrhage, interstitial inflammatory infiltrate 
and congestion, we considered the histological 
compartmentalization, i.e., alveolar spaces, (axial, 
Table 1 - Composition of the preservation solutions used in the study.
HTKa LPDb
Composition Concentration Composition Concentration
Sodium chloride 15 mmol/L Sodium chloride 138 mmol/L
Potassium chloride 9 mmol/L Potassium chloride 6 mmol/L
Potassium hydrogen 2-ketoglutarate 1 mmol/L Magnesium 0.8 mmol/L
Magnesium chloride hexahydrate 4 mmol/L Phosphate 0.8 mmol/L
Histidine.HCl.H2O 18 mmol/L Chloride 142 mmol/L
Histidine 180 mmol/L Glucose 5 mmol/L
Tryptophan 2 mmol/L Dextran 40 50 g/L
Mannitol 30 mmol/L - -
Calcium chloride 0.015 mmol/L - -
pH 7.40-7.45 (4°C) pH (buffer solution) 7.4 (4°C)
Osmolality 310 mOsmol/L Osmolality 295 mOsmol/L
HTK: histidine-tryptophan-ketoglutarate; and LPD: low-potassium dextran. aCustodiol®; Franz Kohler Chemie GMBH, 
Bensheim, Germany. bPerfadex®; Vitrolife, Kungsbacka, Sweden.
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Results 
Histopathological examination revealed 
no significant differences among the LPD-6, 
HTK-6, and NS-6 groups or among the LPD-12, 
HTK-12, and NS-12 groups, as well as revealing no 
significant ischemia-related differences between 
the groups (i.e., LPD-6 vs. LPD-12, HTK-6 vs. 
HTK-12, and NS-6 vs. NS-12), in terms of the 
following parameters: pulmonary congestion; 
alveolar hemorrhage; interstitial hemorrhage; 
and interstitial inflammatory infiltrate (Table 2). 
In all groups, the occurrence of alveolar edema 
was significantly more common after 12 h of 
ischemia than after 6 h of ischemia (Figure 1). 
Analysis of the frequency distribution of edema 
among the groups revealed that the proportion 
of edema was highest in the NS-12 group, and 
that the NS-12 group was the only group in 
which all of the lungs showed alveolar edema 
at the end of the reperfusion; in addition, the 
difference among the LPD-12, HTK-12, and 
NS-12 groups was significant (p = 0.007). The 
same did not occur in the comparison among 
the LPD-6, HTK-6, and NS-6 groups (p = 0.08). 
fragment, followed by incubation under Parafilm 
for 60 min in a humidified chamber at 37°C. The 
assay is employed to label DNA strand breaks 
(with TdT) in each fragment. The assay catalyzes 
the polymerization of labeled nucleotides at the 
3’-OH ends of DNA independently (TUNEL reaction) 
per sample, therefore allowing the detection of 
DNA strand breaks in the early stages of lung cell 
apoptosis. After the incubation period (TUNEL 
reaction), the slides were washed in PBS three 
times (2 min each). The area around the fragment 
was dried, and the slides were mounted with 
glycerin solution and PBS (1:1), were coverslipped 
and protected from light, and were immediately 
analyzed under a fluorescence microscope (Carl 
Zeiss, Oberkochen, Germany), through which 
labeled apoptotic cells were quantified in five 
random fields (magnification, ×40). The readings 
were performed by two investigators, who were 
blinded to the TUNEL reaction quantification. 
Microscopic field selection was random, the 
microscopic fields being always in the alveolar 
region. Five microscopic fields were selected, as 
it is done when reading H&E-stained slides. The 
identified cells were specific, and counts included 
the total number of cells in the selected region. 
In the statistical analysis, we used mixed ANOVA 
and the Bonferroni test for parametric variables. 
For non-parametric quantitative data, we used the 
Kruskal-Wallis test and the Mann-Whitney test. 
For qualitative data, we used the chi-square test 
and Fisher’s exact test. The level of significance 
was set at 5% (p < 0.05). The statistical analyses 
were performed with the Statistical Package 
for the Social Sciences, version 13.0 (SPSS Inc., 
Chicago, IL, USA). 
Table 2 - Comparison of histopathological findings among the groups studied.
Parameter
Values of p in the comparison among the groupsa
LPD-6 LPD-12 
LPD-6 HTK-6 NS-6
vs. HTK-6 vs. HTK-12
vs. NS-6 vs. NS-12 vs. LPD-12 vs. HTK-12 vs. NS-12
Congestion 0.797 0.135 0.370 1.000 0.370
Alveolar hemorrhage 0.077 0.701 0.087 1.000 1.000
Interstitial hemorrhage 0.103 0.943 0.087 1.000 0.303
Inflammatory infiltrate 0.278 0.441 0.350 1.000 0.582
Interstitial infiltrate 0.067 0.315 0.303 0.350 1.000
LPD: low-potassium dextran; HTK: histidine-tryptophan-ketoglutarate; and NS: normal saline. aGroups: LPD-6: LPD 
solution and 6 h of ischemia; LPD-12: LPD solution and 12 h of ischemia; HTK-6: HTK solution and 6 h of ischemia; 
HTK-12: HTK solution and 12 h of ischemia; NS-6 = NS solution and 6 h of ischemia; and NS-12: NS solution and 
12 h of ischemia.
Figure 1 - Histological sections of rat lung tissue 
after 6 h (in A) and 12 h (in B) of ischemia in the 
normal saline group. The arrows show the presence 
of alveolar edema in B (H&E; magnification, ×100). 
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The LPD solution was developed nearly two 
decades ago,(17,18) and its experimental results 
have been shown to be superior to those of most 
solutions.(19) The development of preservation 
solutions for exclusive use in lung preservation 
has reduced the incidence of acute graft failure 
from 30% to less than 15%.(3) Despite the 
evidence, controversy remains regarding the 
benefits of the LPD solution in terms of late 
graft performance and one-year mortality after 
transplantation.(20) More recently, the introduction 
of ex vivo lung reconditioning(21) and donation 
after cardiocirculatory death(4) have reignited 
the controversy and underscored the need to 
re-evaluate the preservation solutions that are 
currently used. 
The HTK solution is used as a cardioplegic 
solution, as well as being used for heart 
preservation for transplantation. Since its 
development, several changes have been made 
to its formulation, making it more effective 
during longer periods of ischemia.(22) However, 
the use of HTK solution for lung preservation 
had not been tested in an ex vivo model. If the 
solution proved effective for this purpose, it 
would be possible to use a single solution for 
cardiopulmonary extraction. 
In the present study, we used an ex vivo lung 
perfusion model to evaluate HTK, comparing it 
with an extracellular solution commonly used 
in lung transplantation (i.e., LPD). We used an 
ex vivo rat lung preparation in which the lungs 
were perfused with homologous venous blood 
obtained by exsanguination of animals of the 
same species.(22,23) The ex vivo perfusion system 
is simple and reproducible, which is why it is 
widely used in studies of lung preservation for 
Nevertheless, in the HTK-6 group, the frequency 
of edema was 30%, whereas, in the LPD-6 group, 
it was 55.6%; however, the difference was not 
significant (p = 0.08; Figure 2). 
There was no significant difference between 
the LPD-6 and LPD-12 groups in terms of the 
number of apoptotic cells (p = 0.319). The same 
occurred in the comparisons between the HTK-6 
and HTK-12 groups (p = 0.258) and between 
the NS-6 and NS-12 groups (p = 0.226). In 
addition, no significant differences were found 
among the LPD-6, HTK-6, and NS-6 groups (p 
= 0.580) or among the LPD-12, HTK-12, and 
NS-12 groups regarding the number of apoptotic 
cells (p = 0.591; Figure 3). 
Discussion 
The present study demonstrated that the 
histopathological characteristics were similar 
between the lungs perfused with either LPD 
or HTK preservation solutions. These findings 
are in accordance with the physiological data 
from the same study, which were published 
previously. The relative oxygenation capacity 
of the lungs undergoing 12 h of ischemia was 
found to be reduced, as were the respiratory 
mechanics parameters. The physiological data 
were recently published and demonstrated that 
the lungs preserved with either LPD or HTK had 
a similar functional performance.(11) 
Ischemia-reperfusion injury is a factor limiting 
donor organ viability, as well as being implicated 
as a contributing factor in the development of 
bronchiolitis obliterans.(16) The combination of 
hypothermia with preservation solutions remains 
the most widely used preservation method. 
Figure 2 - Frequency of alveolar edema in lungs preserved with low-potassium dextran (LPD) solution, 
histidine-tryptophan-ketoglutarate (HTK) solution, or normal saline at two ischemia periods: 6 h (in A) 
and 12 h (in B). Note that the occurrence of alveolar edema was significantly more common in the groups 
undergoing 12 h of ischemia, the incidence being highest in the normal saline group.
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study confirmed this impression, given that all 
of the lungs in the NS group were edematous. 
In our previous study, we found increased 
lung compliance in the lungs undergoing 6 h 
of ischemia and increased lung resistance in 
those undergoing 12 h of ischemia. We also 
found that there was no difference in relative 
oxygenation capacity between the lungs in the 
LPD-6 and LPD-12 groups or among the 12-h 
ischemia groups.(11) 
We focused the present study on 
histopathological examination, with the conviction 
that our findings of morphological changes and 
apoptosis would support our previous physiological 
findings. We chose to include morphological 
parameters whose changes are relevant and related 
to vascular endothelial injury and to changes in the 
lung parenchyma, all of which are representative 
of postischemic reperfusion injury. We found 
no significant differences among the groups 
in terms of congestion, alveolar hemorrhage, 
interstitial hemorrhage, inflammatory infiltrate, 
or interstitial infiltrate. However, we found an 
increase in alveolar edema in the NS-12 group. 
This confirms the assumption that the use of 
NS solution in lung preservation causes severe 
edema on reperfusion, especially in prolonged 
periods of ischemia. 
Cell death in ischemia-reperfusion-induced 
injury is caused by necrosis and apoptosis 
(programmed cell death). Apoptosis can be 
activated during the initial phases of reperfusion 
after lung ischemia.(18) Apoptosis differs from 
necrosis not only from a morphological standpoint 
but also with regard to mediators and biological 
mechanisms of injury. During apoptosis, there is 
a regulated, energy-dependent cascade of events, 
which activate specific endonucleases, such as 
caspases, which are involved in the initiation 
and execution phases of apoptosis.(26,27) 
The duration of ischemia directly influences 
the degree of apoptosis in the tissues. The study 
of the biological pathways of apoptosis in various 
tissues suggests that the cascade of events begins 
during the period of ischemia. However, signs 
of apoptosis appear only during reperfusion, 
whereas cell necrosis occurs during ischemia.(26) 
There is nevertheless unequivocal evidence that 
ischemia alone is not sufficient to trigger apoptosis. 
This has been demonstrated in cardiomyocytes, 
in which ischemia without reperfusion led only 
to cell death by necrosis. Burns et al. used the 
transplantation. We used homologous blood 
obtained by exsanguination of 2 or 3 rats per 
heart-lung block and diluted in NS. Although 
hemodilution affects gas exchange, we obtained 
reliable and consistent blood gas analysis results. 
Hemodilution and its effects on reperfusion 
injury are well known. Puskas et al.(24) employed 
a similar ex vivo perfusion model, in which 
hemodilution was performed with a crystalloid 
solution, having found a reduction in ischemia-
reperfusion injury following ischemia. In the present 
model, it is possible that hemodilution was greater 
in the lungs in the NS-6 and NS-12 groups, given 
that the vascular bed of those lungs had been 
filled with NS before reperfusion. Therefore, in 
our laboratory, NS was recently replaced with 
Krebs solution, given that the solution was found 
to be more effective in producing hemodilution, 
especially in experiments with prolonged periods 
of ischemia. 
In the present study, even the lungs undergoing 
6 or 12 h of ischemia provided consistent data for 
analysis; other authors have limited the periods of 
ischemia to 2-4 h.(25) Although NS is not employed 
in clinical or experimental lung preservation, 
our experimental design included an NS group. 
The choice to include an NS group was based 
on the capacity of NS to cause lung edema on 
reperfusion, a factor that allowed NS to be used 
as a parameter of edema in the comparison with 
the other solutions. Using the same model, we 
previously demonstrated that lungs preserved 
with NS for 12 h showed consistently worse 
performance than did those preserved with the 
other solutions for the same period of ischemia.(11) 
The histopathological findings of the present 
Figure 3 - Photomicrographs of rat lung tissue labeled 
by the TdT-mediated dUTP nick end labeling (TUNEL) 
method. In A, lung tissue undergoing 6 h of hypothermic 
ischemia with the use of low-potassium dextran solution 
and containing few apoptotic cells (arrows). In B, lung 
tissue undergoing 12 h of hypothermic ischemia with 
the use of saline and containing an increased number 
of apoptotic cells (TUNEL; magnification, ×40).
An experimental rat model of ex vivo lung perfusion for the assessment  
of lungs regarding histopathological findings and apoptosis: low-potassium  
dextran vs. histidine-tryptophan-ketoglutarate
J Bras Pneumol. 2012;38(4):461-469
467
2. Hertz MI, Taylor DO, Trulock EP, Boucek MM, Mohacsi PJ, 
Edwards LB, et al. The registry of the international society 
for heart and lung transplantation: nineteenth official 
report-2002. J Heart Lung Transplant. 2002;21(9):950-70. 
http://dx.doi.org/10.1016/S1053-2498(02)00498-9
3. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-
reperfusion-induced lung injury. Am J Respir Crit Care 
Med. 2003;167(4):490-511. http://dx.doi.org/10.1164/
rccm.200207-670SO
4. Cypel M, Sato M, Yildirim E, Karolak W, Chen F, 
Yeung J, et al. Initial experience with lung donation 
after cardiocirculatory death in Canada. J Heart Lung 
Transplant. 2009;28(8):753-8. http://dx.doi.org/10.1016/j.
healun.2009.05.009
5. Gohrbandt B, Sommer SP, Fischer S, Hohlfeld JM, Warnecke 
G, Haverich A, et al. Iloprost to improve surfactant function 
in porcine pulmonary grafts stored for twenty-four hours 
in low-potassium dextran solution. J Thorac Cardiovasc 
Surg. 2005;129(1):80-6. http://dx.doi.org/10.1016/j.
jtcvs.2004.04.040
6. Fischer S, Maclean AA, Liu M, Cardella JA, Slutsky AS, 
Suga M, et al. Dynamic changes in apoptotic and necrotic 
cell death correlate with severity of ischemia-reperfusion 
injury in lung transplantation. Am J Respir Crit Care 
Med. 2000;162(5):1932-9.
7. Ringe B, Braun F, Moritz M, Zeldin G, Soriano H, Meyers 
W. Safety and efficacy of living donor liver preservation 
with HTK solution. Transplant Proc. 2005;37(1):316-9. 
http://dx.doi.org/10.1016/j.transproceed.2004.12.009
8. Eghtesad B, Aucejo F, Fung JJ. Preservation solutions 
in liver transplantation: what are the options? Liver 
Transpl. 2006;12(2):196-8. http://dx.doi.org/10.1002/
lt.20698
9. Potdar S, Malek S, Eghtesad B, Shapiro R, Basu A, Patel 
K, et al. Initial experience using histidine-tryptophan-
ketoglutarate solution in clinical pancreas transplantation. 
Clin Transplant. 2004;18(6):661-5. http://dx.doi.
org/10.1111/j.1399-0012.2004.00262.x
10. Pêgo-Fernandes PM, Werebe Ede C, Cardoso PF, Pazetti R, 
Oliveira KA, Soares PR, et al. Experimental model of isolated 
lung perfusion in rats: technique and application in lung 
preservation studies. J Bras Pneumol. 2010;36(4):490-3.
11. Simões EA, Pêgo-Fernandes PM, Cardoso PF, Pazetti 
R, Werebe E, de Oliveira Braga KA, et al. Comparing 
the performance of rat lungs preserved for 6 or 12 
hours after perfusion with low-potassium dextran 
or histidine-tryptophan-ketoglutarate. Transplant 
Proc. 2011;43(5):1520-4. http://dx.doi.org/10.1016/j.
transproceed.2010.12.001
12. Cardoso PF, Pazetti R, Moriya HT, Pêgo-Fernandes PM, 
Almeida FM, Correia AT, et al. An experimental rat 
model of ex vivo lung perfusion for the assessment of 
lungs after prostacyclin administration: inhaled versus 
parenteral routes. J Bras Pneumol. 2011;37(5):589-97. 
http://dx.doi.org/10.1590/S1806-37132011000500005
13. Canzian M, de Matos Soeiro A, de Lima Taga MF, Farhat 
C, Barbas CS, Capelozzi VL. Semiquantitative assessment 
of surgical lung biopsy: predictive value and impact on 
survival of patients with diffuse pulmonary infiltrate. 
Clinics (Sao Paulo). 2007;62(1):23-30. http://dx.doi.
org/10.1590/S1807-59322007000100005
14. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification 
of programmed cell death in situ via specific 
labeling of nuclear DNA fragmentation. J Cell 
TUNEL method to study apoptosis before and 
after reperfusion in kidney transplantation and 
found that the degree of apoptosis was lesser 
before reperfusion, suggesting that apoptosis 
occurs predominantly after reperfusion.(28) The 
induction of lung ischemia by pulmonary artery 
ligation in pigs resulted in chronic lung ischemia 
and overexpression of pro-apoptotic factors. The 
addition of reperfusion after chronic ischemia 
triggers massive apoptosis, leading to endothelial 
injury.(29) Various studies have demonstrated that 
the inhibition of apoptosis by caspase inhibitors 
results in reduced lymphocyte infiltration and cell 
death, which leads to improved lung function.(6,30) 
In the present study, the assessment of 
apoptosis by the TUNEL method revealed no 
significant differences in the number of apoptotic 
cells between the 6-h period of ischemia and 
the 12-h period of ischemia in the LPD, HTK, 
or NS groups after 60 min of lung reperfusion. 
This finding can be interpreted in two different 
ways: first, the lack of differences might be 
due to severe ischemic injury, which was similar 
among the groups; second, the LPD and HTK 
solutions might be similar in terms of the quality of 
preservation (cell integrity). Therefore, the degrees 
of apoptosis associated with the two solutions 
might be similar. The lack of differences between 
the NS group and the other groups (LPD and HTK) 
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functional performance of lungs preserved with 
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